TokenPost·
CytoSorbents Shares Rose 34% on Oct. 16 Ahead of Nasdaq Deadline
34%
share gain
The stock closed at $4.11, below its $6.85 split-adjusted close on Sept. 8. Nasdaq’s separate $35 million market-value requirement has a Dec. 28 deadline.
More news
- TokenPostIran Says It Is Reviewing U.S. Comments on Hormuz Proposal
- Crypto BriefingTRON handles about 73% of stablecoin transaction volume in September 2026
- TokenPostContract Account With Over $20 Million in Cumulative Profits Opens $5.6 Million ZEC Short
- Crypto BriefingEx-OpenAI engineer accused of espionage had Saudi backing, prosecutors say
- TokenPostSilhouette Adds Bitcoin and HYPE Perpetuals to RFQ Trading
- Crypto BriefingOndo and Superstate lead weekly growth in tokenized US T-bill market